Related Experiment Video
Updated: Apr 16, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Lifestyle effects on hematopoiesis and atherosclerosis
Matthias Nahrendorf1, Filip K Swirski1
1From the Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston. mnahrendorf@mgh.harvard.edu fswirski@mgh.harvard.edu.
Insights
Lifestyle factors like diet and stress impact chronic inflammatory diseases by altering immune cell production. This study explores how these factors influence hematopoietic processes, potentially affecting atherosclerosis risk.
Area of Science:
- Cardiovascular Science
- Immunology
- Hematology
Background:
- Chronic inflammatory diseases, such as atherosclerosis, are influenced by lifestyle factors including diet, exercise, stress, and sleep.
- Psychosocial stress and poor diet exacerbate cardiovascular disease, while exercise and good sleep habits are protective.
- The role of inflammation-associated leukocyte production in mediating lifestyle effects on atherosclerosis is under investigation.
Purpose of the Study:
- To investigate how lifestyle factors influence the molecular and cellular mechanisms of hematopoiesis.
- To explore the hypothesis that lifestyle can alter hematopoietic topography, shifting immune cell production.
- To understand the impact of these changes on the macrophage supply chain and atherosclerosis progression.
Main Methods:
- The study focuses on exploring the mechanistic links between lifestyle modifiers and hematopoiesis.
- It examines how external factors influence progenitor-extrinsic and intrinsic communication nodes.
- The research investigates neuroimmune and immunometabolic axes in relation to immune cell production.
Main Results:
- Lifestyle factors may rearrange hematopoietic topography, diverting immune cell production from bone marrow to periphery.
- This shift can lead to quantitative and qualitative changes in the macrophage supply chain.
- Altered macrophage number and phenotype in lesions are potential consequences.
Conclusions:
- Inflammation-associated leukocyte production is proposed as a key mediator of lifestyle effects on atherosclerosis.
- Future therapeutics could target the hematopoietic tree's output and location to mitigate atherosclerosis risk.
- Public health policies should consider these lifestyle-hematopoiesis interactions.
Abstract:
Diet, exercise, stress, and sleep are receiving attention as environmental modifiers of chronic inflammatory diseases, including atherosclerosis, the culprit condition of myocardial infarction and stroke. Accumulating data indicate that psychosocial stress and a high-fat, high-cholesterol diet aggravate cardiovascular disease, whereas regular physical activity and healthy sleeping habits help prevent it. Here, we raise the possibility that inflammation-associated leukocyte production plays a causal role in lifestyle effects on atherosclerosis progression. Specifically, we explore whether and how potent real-life disease modifiers influence hematopoiesis' molecular and cellular machinery. Lifestyle, we hypothesize, may rearrange hematopoietic topography, diverting production from the bone marrow to the periphery, thus propagating a quantitative and qualitative drift of the macrophage supply chain. These changes may involve progenitor-extrinsic and intrinsic communication nodes that connect organ systems along neuroimmune and immunometabolic axes, ultimately leading to an altered number and phenotype of lesional macrophages. We propose that, in conjunction with improved public health policy, future therapeutics could aim to modulate the quantitative and qualitative output, as well as the location, of the hematopoietic tree to decrease the risk of atherosclerosis complications.
Related Concept Videos
Atherosclerosis III: Management
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Coronary Artery Disease I: Introduction
Regulation of Hematopoietic Stem Cells
Atherosclerosis I: Introduction

